Vanguard Capital Management
MNOV icon

Vanguard Capital Management’s MediciNova MNOV Stock Holding History

Vanguard Capital Management’s Portfolio MNOV Stock Details MNOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$804K Sell
609,052
-1,987
-0.3% -$2.73K ﹤0.01% 3633
2026
Q1 		$837K Buy
+611,039
New +$925K ﹤0.01% 3585

Other funds holding MNOV

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vanguard Capital Management's MNOV Position: Q2 2026 in Review

Vanguard Capital Management reduced its MediciNova (MNOV) stake by 0.33% in Q2 2026, selling an estimated $2.73K and leaving 609,052 shares worth $804K. The position accounts for ﹤0.01% of the portfolio, ranked #3633.

Vanguard Capital Management first reported a position in MNOV in Q1 2026 and has held it in 2 quarters since. The position peaked at $837K in Q1 2026. 28 funds tracked by Wall St. Rank hold MNOV as of Q2 2026.

  • Vanguard Capital Management held 609,052 shares of MediciNova worth $804K as of Q2 2026.
  • Vanguard Capital Management sold 1,987 MediciNova shares in Q2 2026, an estimated $2.73K.
  • MediciNova made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3633 holding.
  • Vanguard Capital Management first reported a position in MediciNova in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's MediciNova position peaked at $837K in Q1 2026.
  • 28 funds tracked by Wall St. Rank held MediciNova as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.